Store
In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
Publication Date: November 7, 2023
Tags: Coagulation, COVID-19, Diagnostic Instruments, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: 40
SKU: 23-046
As in vitro diagnostic (IVD) testing returns to its vital role in healthcare, it remains a cornerstone in medical practice, providing crucial insights for physicians, from diagnosis to precision medicine. While COVID-19 testing sees a decline, it continues to influence total revenues for 2023. In this ever-changing landscape, characterized by new products, shifts in global health spending, regulatory updates, and evolving disease trends, IVD remains resilient.
Kalorama Information’s IVD Trends and Market Update: November 2023 is your definitive guide to the latest market trends and insights. This report, updated by Kalorama’s analysts in Q3 2023, offers the most current information on the IVD market.
Key Market Segments:
- Point-of-Care
- Next-Generation Sequencing (NGS)
- Cancer Testing
- Companion Diagnostics
- Immunochemistry
- Mass Spectrometry
- Gene Testing
- Molecular Diagnostics
Highlighted Trends in Q3 2023:
- Proliferation of Multiplex Testing
- Adoption of AI Technologies
Why Choose Kalorama Information:
Kalorama Information is renowned for its in-depth analysis of the IVD market, thanks to the expertise of its authors and its commitment to delivering precise and timely data.
Discover:
- What’s Driving Growth in the IVD Market in Q3 and the Second Half of 2023
- Major Trends Affecting the Market in Q3 and the Second Half of 2023
- Impact of COVID-19 on the Market in Q3 and the Second Half of 2023
- Product Trends and New Developments Shaping the IVD Market in the Second Half of 2023
Stay Informed, Stay Competitive:
As the IVD market evolves, it’s crucial to stay informed. Kalorama’s IVD Trends and Market Update: November 2023 provides the insights you need to navigate this dynamic industry. Order your copy today to stay ahead of the curve.
Table: COVID-19 Product Sales, by Segment, 2023 ($ millions)
| Segment | 2023 | %Mkt |
| COVID-19 Lab-based Immunoassay Sales (Antigen & Serology) | $XX Million | XX% |
| COVID-19 Lab-based Molecular Sales | $XX Million | XX% |
| COVID-19 Rapid Sales (POC Professional and POC At-Home) | $XX Million | XX% |
| Total COVID-19 | $XX Million | XX% |
Re-evaluated October 2023
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Worldwide IVD Market – October 2023 Update
IVD Market Demand and Growth
Figure 1-1: Q3 Segment Performance Commentary, 2023
- Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2023 ($ million) (Clinical Chemistry; Immunoassays – non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab]; Hematology – Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology – Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
- Figure 1-2: IVD Segment Performance, Q1 2023 – Q4 2023e ($MN)
- Figure 1-3: IVD Segment Performance (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other), Total Market Value, 2023 ($MN) Estimated
COVID-19 Diagnostic Markets
- Table 1-2: COVID-19 Product Sales, by Segment (Immunoassay [Antigen, Serology], Molecular, Rapid [POC Professional, POC At-Home]), 2023 ($ millions)
Effect of COVID-19 on Market Segments
- Table 1-3: IVD Market (excluding and with COVID-19), 2023 ($ millions)
- Figure 1-4: IVD Market Distribution, by Segment (COVID-19 Assays and Instruments, IVD Market excluding COVID-19 Assays and Instruments), 2023 (%)
- Figure 1-5: IVD Market by COVID-19 and non-COVID Markets, Quarterly Performance, 2023 Estimated ($ millions)
- Table 1-4: Global In Vitro Diagnostic Market, by Segment (Clinical Chemistry; Immunoassays – non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab]; Hematology – Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Coagulation [PT/INR]; Histology/cytology; d-dimer; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; POC, OTC diabetes; POC, OTC other; POC, professional/hospital), YoY Growth 2022-2023 (%)
- Figure 1-6: Global In Vitro Diagnostic Market, by Segment (Clinical Chemistry; Immunoassays – non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab]; Hematology – Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Coagulation [PT/INR]; Histology/cytology; d-dimer; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; POC, OTC diabetes; POC, OTC other; POC, professional/hospital), YoY Growth 2022-2023 (%)
Chapter 2: Product Trends and New Developments
Selected New – Q3 2023 – Core IVD Product Launches, Developments and Trends
Clinical Chemistry
Flow Cytometry
Immunoassay
Mass Spectrometry
Molecular
Personalized Medicine
POC
Sequencing
Selected COVID-19 Developments – Q3 2023
- Figure 2-1: COVID-19 Test Market, by Type (Antigen, Molecular, Serology, Rapid), Q1-Q4 2023 ($ millions)
Antigen/Antibody
Molecular
Chapter 3: Top IVD Market Participant Results
Selected Competitive Leader Updates
- Figure 3-1: IVD Segment Growth, by Leading Competitors (Abbott Diagnostics, Becton Dickinson, bioMérieux, Danaher, Exact Sciences, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific), Change in Sales, 2022-2023 (%)
- Figure 3-2: Changes in Market Distribution for IVD Sales, 2020-2023 – Roche and Abbott Battle for #1 Spot
- Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche, 2020-2023 ($ millions)
Q3 M&A Activity
Table 3-1: Q3 2023 Merger and Acquisition Activity
Abbott Laboratories
- Table 3-2: Abbott Corporate Summary
Becton Dickinson and Co
- Table 3-3: Becton Dickinson Corporate Summary
bioMérieux SA
- Table 3-4: bioMérieux Corporate Summary
Danaher Corporation
- Table 3-5: Danaher Corporation Summary
Hologic, Inc.
- Table 3-6: Hologic Corporate Summary
QuidelOrtho Corporation
- Table 3-7: QuidelOrtho Corporate Summary
Roche Diagnostic
- Table 3-8: Roche Diagnostic Corporate Summary
Siemens Healthineers
- Table 3-9: Siemens Healthineers Corporate Summary
Sysmex Corporation
- Table 3-10: Sysmex Corporate Summary
Thermo Fisher Scientific
- Table 3-11: Thermo Fisher Scientific Corporate Summary
Chapter 4: New Opportunities
Multiplex Testing
Next-Generation Sequencing
Artificial Intelligence Future Trends
Disruptive Technologies
Related products
The Worldwide Market for Clinical Laboratory Services, 9th Edition
June 25, 2024
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…
$5,000.00 – $7,500.00
In Vitro Diagnostic (IVD) Trends and Market Update: March 2024
March 26, 2024
Explore the latest trends and developments in the in vitro diagnostic (IVD) market with Kalorama Information’s comprehensive report, In Vitro Diagnostic (IVD) Trends and Market Update: March 2024. Gain insights into key growth segments, industry trends, and emerging technologies shaping the future of IVD.
The report offers updated data analysis based on Kalorama Information’s annual…
$5,000.00 – $7,875.00
In Vitro Diagnostics Business Outlook, 2024
December 20, 2024
In Vitro Diagnostics Business Outlook, 2024 is a must-have publication offering exclusive information and data that cannot be found elsewhere. With a focus on the in vitro diagnostics (IVD) market, this publication provides valuable insights to help businesses identify growth opportunities, understand market trends, and tailor strategies for success.
Key Features:
…
$4,995.00 – $9,995.00
